The new book “Global Health Impacts of Nanotechnology Law” by Ilise L. Feitshans gives a thorough inside into the relation between law and science in nanotechnology

If you are scientist, journalist, lawyer, policymaker, bioethicist or a member of a NGO or just interested in nanotechnology, this book gives you answers to your questions.

Nanotechnology will revolutionize the industry as well as everyday life of us all. Benefits are apparent but there is a huge knowledge gap concerning the risk for health and environment.

What role will laws and regulation play? What are the tasks of stakeholders? How can society benefit from the new technology while avoiding new and old dangers?

You can order the book right here with amazon.com / amazon.de / amazon.fr / amazon.it / amazon.es / amazon.co.uk and many more

Or you order the book with my distributor USA crc press

Occupational Health and Safety: How to protect workers from potential risks?

What did society learn from the catastrophy which asbestos brought to so many workers. families and the industry? Dr. Feitshans discusses the lessons learned from asbestos. But will they prevent a similar tragedy from nanotechnology? What does a comparison between the asbestos case and the new nanomaterials reveal?

Will the industry in the future delay disclosure of dangers like they did in the past with asbestos? Or will there be prompt disclosure of risks and hazards? What role does risk management and the precautionary principles play in safeguarding safety and health?

To find out more about the writings of Dr. Feitshans about Occupational Health and Safety follow this link: www.whs-project.org

Do we need more laws and regulations to avoid hazard through nanotechnology?

Sciensts and governments agree that the application of nanotechnology to commerce poses important risks to human health and environment. The science of protecting public health lags behind the science of research that creates new nanomaterials. What law could protect the general public, nanotechnology workers and their corporate social partners from both liability and preventable harms?

Dr. Feitshans discusses the issues which occur within the process of creatiing a regulatory framework to protect life and public health. How can we define nanotechnology to be able to write laws? Or will it be sufficient to modify established regulations?

Follow this link to find out more about the writings of Dr. Feitshans about nanotechnology and law: www.whs-project.org

Will nanomedicine redefine old concepts such as disability and health? Which bioethical issues will come up as a consequence?


Nanotechnology will treat diseases sooner, possibly even while the people who are expected to become ill are still healthy. The presymptomatic recognition of illness will therefore expand the definition of disability.

Furthermore there is extensive overlap between nanotechnologies and genetic sciences. For example, the ability to choose fetal characteristics will revive many bioethical issues. The author discusses the key role of nanotechnology in enabling personalized, targeted and regenerative medicine.

To find out more about the writings of Dr. Feitshans about Genetics follow this link: www.whs-project.org

About me

Dr. Ilise Feitshans, JD , ScM and DIR is a bi-lingual jurisprude. Ilise currently serves as a Fellow in Nanotechnology Law at the European Scientific Institute in Archamps, France, (affiliated with CERN and with the University of Grenoble) and as the Executive Director of the Work Health and Survival Project. Ilise’s Doctorate in International Relations “Forecasting Nano Law: Risk Management Protecting Public Health Under International Law” at the Geneva School of Diplomacy, Geneva Switzerland, won the prize for the Best research in social medicine and prevention at the University of Lausanne in 2014.

In addition to her diplomacy doctorate and a juris doctor in law, Ilise has a Masters of Science in Public Health from the Johns Hopkins University, where she studied the impact of genetic testing during pregnancy upon womens medical decisionmaking. Ilise is a Member of the Bar of the Supreme Court of the USA and is a Former Member of the Faculty/ Acting Director, Legislative Drafting Research Fund, Columbia University School of Law in the City of New York. She also served as Coordinatrice for the United Nations ILO Encyclopaedia of Occupational Health and Safety in Geneva Switzerland as an international civil servant, and then, as Visiting Scientist, University of Lausanne Institute for Work and Health, Lausanne Switzerland.

Follow this link to find out more about books and writings by Dr. Feitshans: www.whs-project.org